Global Healthcare Company Selects Emerson To Help Address Growing Diabetes Epidemic
Emerson’s automation technologies and project strategies to help Novo Nordisk achieve tight project schedule and rapid construction of manufacturing site for critical medicines
Global healthcare company Novo Nordisk has awarded Emerson (NYSE: EMR) a $40 million automation systems and services contract for a new US-based drug manufacturing facility to help battle the global diabetes epidemic.
The largest project in its history, Novo Nordisk’s new $2 billion plant in Clayton, North Carolina, will leverage Emerson’s Project Certainty methodologies and automation technologies to help ensure the plant meets its operational target of 2020.
The new 825,000-square-foot production facility will help the Danish drug company increase manufacturing capacity and meet its goal of doubling production of diabetes drugs over the next decade.
According to the Centers for Disease Control and Prevention, more than 29 million Americans are living with diabetes, with another 86 million living with prediabetes.
“Our extensive experience in the life sciences industry and integrated offering for capital projects and automation perfectly positions us to help Novo Nordisk deliver its largest project in history,” said Mike Train, executive president, Emerson Automation Solutions. “Together we can design and deliver this world-class manufacturing facility to be ready on time, and to quickly bring these important diabetes medicines to patients.”
Novo Nordisk will implement elements of Emerson’s Project Certainty approach to help reduce project complexity and achieve the tight project schedule.
This transformational approach leverages automation technology, which serves as a central nervous system in a plant, and new methodologies, to reduce costs and complexity and accommodate late-stage project changes.
Novo Nordisk selected Emerson’s integrated portfolio of automation technologies and services, including its DeltaV™ distributed control system (DCS) and Syncade manufacturing execution system (MES). Emerson will also provide smart automation technologies including valves and measurement instrumentation.
For more information about Emerson’s life sciences capabilities, go to www.Emerson.com/lifesciences.
For more information on Emerson’s Project Certainty methodologies, go to www.Emerson.com/project-certainty.
Emerson Automation Solutions
- 0870 240 1978
- uksales@emerson.com
- Meridian East, Meridian Business Park, Leicester, Leicestershire LE19 1UX GB
About us
Leader in helping businesses automate their production, processing and distribution in the chemical, oil and gas, refining, pulp and paper, power, water and wastewater treatment, mining and metals, food and beverage, life sciences and other industries.
Where we supply to
Europe, Africa, Asia, Australia, South America, North America
Industries we supply to
Automation, Chemicals, Consultants, Components Electronics, Energy and Power, Food and Beverage, Glass Ceramics Cement, Metals and Minerals, OEM, Paper and Pulp, Pharmaceutical Cosmetics Toiletries, Plastics and Rubber, Recycling, Textiles, Tobacco, Water and Wastewater
